tiprankstipranks
Recce Pharmaceuticals Embraces ASX Governance Standards
Company Announcements

Recce Pharmaceuticals Embraces ASX Governance Standards

Recce Pharmaceuticals Ltd. (AU:RCE) has released an update.

Don't Miss our Black Friday Offers:

Recce Pharmaceuticals Ltd. has fully adhered to the ASX Corporate Governance Council recommendations for the financial year ended 30 June 2024, as detailed in their Corporate Governance Statement. The company’s governance information, including the board charter and details on director appointments, is accessible on their website. This compliance has been officially confirmed in a statement authorized on 30 August 2024 by Company Secretary Maggie Niewidok.

For further insights into AU:RCE stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskRecce Pharmaceuticals Director Increases Stake with New Options
TipRanks Australian Auto-Generated NewsdeskRecce Pharmaceuticals Boosted by $6.75M R&D Rebate
TipRanks Australian Auto-Generated NewsdeskRecce Pharmaceuticals Issues New Options for Growth
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App